Discontinued — last reported Q3 '23
Treasury Stock, Value
Quest Diagnostics Treasury Stock, Value decreased by 1.7% to $5.09B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.3%, from $4.79B to $5.09B. Over 5 years (FY 2020 to FY 2025), Treasury Stock, Value shows relatively stable performance with a -0.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates an active share buyback program, often signaling management's belief that the stock is undervalued or a commitment to returning capital to shareholders.
Detailed definition
This represents the value of shares that the company has repurchased from the open market and holds in its own treasury....
Peer comparison
Commonly used by mature companies to manage share count and return capital to investors.
equity_treasury_stock_valueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.89B | $2.87B | $3.45B | $3.76B | $3.90B | $4.27B | $4.67B | $4.61B | $4.59B | $4.57B | $4.83B | $4.78B | $4.76B | $4.73B | $4.86B | $4.79B | $4.77B | $4.90B | $5.18B | $5.09B |
| QoQ Change | — | -58.4% | +20.5% | +8.9% | +3.7% | +9.5% | +9.4% | -1.3% | -0.5% | -0.4% | +5.6% | -0.9% | -0.4% | -0.6% | +2.6% | -1.4% | -0.4% | +2.6% | +5.8% | -1.7% |
| YoY Change | — | — | — | — | -43.4% | +49.0% | +35.3% | +22.6% | +17.6% | +7.0% | +3.3% | +3.7% | +3.8% | +3.5% | +0.6% | +0.2% | +0.3% | +3.5% | +6.7% | +6.3% |
Treasury Stock, Value at Other Companies
Frequently Asked Questions
- What is Quest Diagnostics's treasury stock, value?
- Quest Diagnostics (DGX) reported treasury stock, value of $5.09B in Q1 2026.
- How has Quest Diagnostics's treasury stock, value changed year-over-year?
- Quest Diagnostics's treasury stock, value increased by 6.3% year-over-year, from $4.79B to $5.09B.
- What is the long-term trend for Quest Diagnostics's treasury stock, value?
- Over 5 years (2020 to 2025), Quest Diagnostics's treasury stock, value has grown at a -0.7% compound annual growth rate (CAGR), from $5.37B to $5.18B.
- What does treasury stock, value mean?
- The value of company shares that have been bought back from the market.